Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB&M Regulatory News (BME)

Share Price Information for B&M (BME)

Share Price is delayed by 15 minutes
Get Live Data
199.30    2.60 (1.32%)
Bid:
199.00
Ask:
199.30
Spread: 0.30 (0.151%)
Market Cap: £2.00b
BME Live PriceLast checked at - London Stock Exchange

Intraday B&M Share Chart

Covid-19 Update

1 Apr 2020 12:29

RNS Number : 4299I
B&M European Value Retail S.A.
01 April 2020
 

 

 

01 April 2020

B&M European Value Retail S.A.

(the "Company" or "Group ")

 

COVID-19 Update

 

As a significant retailer of food, drink, cleaning, healthcare, pet food and other essential products our B&M UK fascia and Heron Foods businesses have continued to trade following the guidance issued by the UK Government on 23 March 2020. Our first priority has been to protect and support our customers and colleagues. We have implemented Government advice regarding social distancing across our business.

 

In the UK, B&M traded from 656 stores and a further 293 Heron stores as at the 29 March 2020 year-end. We have reluctantly decided to temporarily close 49 B&M UK stores in light of current trading conditions affecting those locations. These are typically small format stores and in some cases are located within shopping centres that have largely ceased trading. Some 42 of the 49 stores are close to other larger B&M stores. We will review the trading patterns on an on-going basis and intend to re-open those stores as soon as normal shopping patterns resume.

 

The rest of our store estate in the UK continues to trade in line with Government guidance. The temporarily closed stores represent 3% and 2% of FY20 revenue and store contribution EBITDA respectively. Colleagues at the affected stores in the UK have been furloughed under the Government's Coronavirus Job Retention Scheme.

 

All our Heron Foods stores continue to trade. Our 101 stores in France under the Babou and B&M fascias are currently closed under the government restrictions in force there. As previously announced, we completed the sale of our German business on 27 March 2020.

 

We are grateful to our committed and hard-working colleagues for their remarkable effort and dedication in our stores and supply chain functions in helping customers at this very challenging time. To reward our store and distribution colleagues the UK business is now paying 10% enhancement to pay rates to reflect the additional workload that the guidelines impose. We have extended our B&M staff discount scheme to all NHS workers, and are donating £1m worth of food and toiletries to Food Banks across the UK.

 

Enquiries

 

B&M European Value Retail S.A.

For further information please contact +44 (0) 151 728 5400 ext 5766

Simon Arora, Chief Executive

Paul McDonald, Chief Financial Officer

Steve Webb, Investor Relations Director

Investor.relations@bandmretail.com

 

Media

For media please contact +44 (0) 207 379 5151

Daniel Yea, Maitland

bmstores-maitland@maitland.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDUPUMPCUPUGGG
Date   Source Headline
9th Dec 20244:00 pmRNSDirector Purchase of Shares
22nd Nov 20244:02 pmRNSDirector Exercise of Share Options
22nd Nov 20244:00 pmRNSDirector Purchase of Shares
19th Nov 20244:52 pmRNSPricing of £250 Million Senior Secured Notes
18th Nov 20248:00 amRNSLaunch of £250 million Senior Secured Notes Offer
14th Nov 20247:00 amRNSFY25 Interim Results
31st Oct 20241:00 pmRNSTiming of Announcement of Interim Results
17th Oct 20243:00 pmRNSTR1: Notification of Major Holding in Company
4th Oct 20245:30 pmRNSDirector Declaration
30th Sep 20242:15 pmRNSTotal Voting Rights
13th Sep 20242:51 pmRNSGrant of Share Options to French Senior Management
12th Sep 20244:31 pmRNSPDMR Exercise of Share Options
3rd Sep 20242:15 pmRNSAppointment To Remuneration Committee
2nd Sep 20245:00 pmRNSTotal Voting Rights
29th Aug 20242:45 pmRNSPDMR Shareholding notification
12th Aug 20245:30 pmRNSGrant of Share Options
31st Jul 20245:29 pmRNSTotal Voting Rights
25th Jul 20245:45 pmRNSGrant of Options to Directors
23rd Jul 20242:57 pmRNSEGM Voting results announcement
23rd Jul 20242:15 pmRNSAGM 2024 Voting results announcement
16th Jul 20244:56 pmRNSBlock listing six monthly return
16th Jul 20247:00 amRNSQ1 FY25 Trading Update
19th Jun 20247:00 amRNSNotice of AGM and EGM
17th Jun 202410:00 amRNSGrant of Share Options
13th Jun 20244:50 pmRNSNotice of FY25 Q1 Trading Statement
7th Jun 20243:25 pmRNSPDMR Purchase of Shares
5th Jun 20247:05 amRNSAppointment of new Chair
5th Jun 20247:00 amRNSFY24 Preliminary Results
29th May 20242:30 pmRNSDirector Appointment & Results of OGM
24th Apr 20249:00 amRNSNotice of Ordinary General Meeting
16th Apr 20247:00 amRNSFY24 Post Close Trading Statement
4th Apr 202410:00 amRNSNotice of FY24 Post Close Trading Statement
22nd Mar 20249:00 amRNSBoard Appointment
8th Feb 20249:00 amRNSConfirmation of timing of FY24 Preliminary Results
1st Feb 20241:00 pmRNSMajor Shareholding in Company TR-1
30th Jan 20246:23 pmRNSHolding(s) in Company
24th Jan 202410:00 amRNSPDMR Purchase of Shares
23rd Jan 202412:00 pmRNSB&M Plans Chairman Succession
18th Jan 20242:46 pmRNSNotification of Major Shareholding
15th Jan 20242:20 pmRNSBlock listing Interim Review
9th Jan 20247:00 amRNSGolden Quarter - strong profitable growth
22nd Dec 202312:00 pmRNSCorrection: PDMR announcement
22nd Dec 20238:30 amRNSPost Stabilisation Notice
19th Dec 20239:04 amRNSPCA Notification
15th Dec 20239:00 amRNSNotification of major holdings
13th Dec 202312:10 pmRNSAnnouncement further to recent placing by SSA
30th Nov 20235:41 pmRNSChange of Registered Office
30th Nov 20234:01 pmRNSTotal Voting Rights
28th Nov 20239:22 amRNSDirector/PDMR Shareholding
27th Nov 20235:13 pmRNSNotice of FY24 Third Quarter Trading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.